Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in low-income countries. However, little information is available on its performance in low-incidence, high-resource countries. METHODS: We evaluated the accuracy of Xpert in a university hospital tuberculosis clinic in Montreal, Canada, for the detection of pulmonary tuberculosis on induced sputum samples, using mycobacterial cultures as the reference standard. We also assessed the potential reduction in time to diagnosis and treatment initiation. RESULTS: We enrolled 502 consecutive patients who presented for evaluation of possible active tuberculosis (most with abnormal chest radiographs, only 18% symptomatic). Twenty-five subjects were identified to have active tuberculosis by culture. Xpert had a sensitivity of 46% (95% confidence interval [CI], 26%-67%) and specificity of 100% (95% CI, 99%-100%) for detection of Mycobacterium tuberculosis. Sensitivity was 86% (95% CI, 42%-100%) in the 7 subjects with smear-positive results, and 28% (95% CI, 10%-56%) in the remaining subjects with smear-negative, culture-positive results; in this latter group, positive Xpert results were obtained a median 12 days before culture results. Subjects with positive cultures but negative Xpert results had minimal disease: 11 of 13 had no symptoms on presentation, and mean time to positive liquid culture results was 28 days (95% CI, 25-47 days) compared with 14 days (95% CI, 8-21 days) in Xpert/culture-positive cases. CONCLUSIONS: Our findings suggest limited potential impact of Xpert testing in high-resource, low-incidence ambulatory settings due to lower sensitivity in the context of less extensive disease, and limited potential to expedite diagnosis beyond what is achieved with the existing, well-performing diagnostic algorithm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is likely that patients in these settings present earlier with more paucibacillary disease, which might result in a decreased sensitivity of Xpert [45].”
From Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (2014) · cites this paper as [45]
Citations
Cites
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124 · cited 2×
“We used Standards for the Reporting of Diagnostic Accuracy [18] [19] for reporting the study results.”
MethodXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationA systematic review of delay in the diagnosis and treatment of tuberculosis
Storla, D. G., Yimer, S., & Bjune, G. A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-15 · Cited by 1,018
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
Behr, M., Warren, S., Salamon, H., Hopewell, P., de Leon, A. P., Daley, C., & Small, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03406-0 · Cited by 754
Self-citationTime delays in diagnosis of pulmonary tuberculosis: a systematic review of literature
Sreeramareddy, C. T., Panduru, K. V., Menten, J., & Van den Ende, J. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-91 · Cited by 455
Tostmann, A., Kik, S. V., Kalisvaart, N. A., Sebek, M. M., Verver, S., Boeree, M. J., & van Soolingen, D. (2008) · Clinical Infectious Diseases · doi:10.1086/591974 · Cited by 320
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253 · cited 2×
“The Xpert assay may enhance accurate and rapid detection, as it can detect up to 67% of smear-negative cases [1].”
BackgroundMethodSelf-citationRifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Van Deun, A., Aung, K. J. M., Bola, V., Lebeke, R., Hossain, M. A., de Rijk, W. B., Rigouts, L., Gumusboga, A., Torrea, G., & de Jong, B. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00553-13 · Cited by 241
Friedrich, S. O., Rachow, A., Saathoff, E., Singh, K., Mangu, C. D., Dawson, R., Phillips, P. P., Venter, A., Bateson, A., Boehme, C. C., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70119-x · Cited by 181
Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
Banada, P. P., Sivasubramani, S. K., Blakemore, R., Boehme, C., Perkins, M. D., Fennelly, K., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01053-10 · Cited by 149
Williamson, D. A., Roberts, S., Bower, J. E., Vaughan, R., Newton, S., Lowe, O., Lewis, C. A., & Freeman, J. T. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0178 · Cited by 106
Iademarco, M. F. (2013) · PubMed Central · Cited by 104
Moure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90 · cited 1×
“Yet, the performance of the test has not been studied in routine use in high-resource, tertiary-care settings with low incidence of tuberculosis [4, 5].”
BackgroundClouse, K., Page‐Shipp, L., Dansey, H., Moatlhodi, B., Scott, L. E., Bassett, J., Stevens, W. S., Sanne, I., & Rie, A. V. (2012) · South African Medical Journal · doi:10.7196/samj.5851 · Cited by 81
Van Rie, A., Mellet, K., John, M.-A., Scott, L., Page-Shipp, L., Dansey, H., Victor, T., & Warren, R. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0395 · Cited by 73
Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States
Choi, H. W., Miele, K., Dowdy, D. W., & Shah, M. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0095 · Cited by 71
Somoskövi, Á., Deggim, V., Ciardo, D., & Bloemberg, G. V. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01377-13 · Cited by 43
Rie, A. V., Page‐Shipp, L., Hanrahan, C. F., Schnippel, K., Dansey, H., Bassett, J., Clouse, K., Scott, L. E., Stevens, W. S., & Sanne, I. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0392 · Cited by 40
Bark, C. M., Gitta, P., Ogwang, S., Nsereko, M., Thiel, B., Boom, W. H., Eisenach, K. D., Joloba, M. L., & Johnson, J. L. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0063 · Cited by 24
Research works printed but not linked: 4
- 2010, Public Health Agency of Canada. Tuberculosis in Canada 2010—pre-release
- Pai, 2013, Canadian Tuberculosis Standards, Canadian Resp J, 20, 16A
- Cepheid, 2013, Xpert MTB/RIF assay (package insert)
- Kent, 1985, Public health mycobacteriology—a guide for the level III laboratory
Cited by
Dorman, S. E., Schumacher, S. G., Alland, D., Nabeta, P., Armstrong, D. T., King, B., Hall, S. L., Chakravorty, S., Cirillo, D. M., Tukvadze, N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30691-6 · Cited by 689
Self-citationChakravorty, S., Simmons, A. M., Rowneki, M., Parmar, H., Cao, Y., Ryan, J., Banada, P. P., Deshpande, S., Shenai, S., Gall, A., et al. (2017) · mBio · doi:10.1128/mbio.00812-17 · Cited by 668
Self-citationDrain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Self-citationAcharya, B., Acharya, A., Gautam, S., Ghimire, S. P., Mishra, G., Parajuli, N., & Sapkota, B. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05413-7 · Cited by 292
Metadata
- Authors
- Sohn, H., Aero, A. D., Menzies, D., Behr, M., Schwartzman, K., Alvarez, G. G., Dan, A., McIntosh, F., Pai, M., & Denkinger, C. M.
- Affiliations
- Montreal Chest Institute (CA)
- University of Ottawa (CA)
- McGill University (CA)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Sohn, Hojoon
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-14
- Volume
- 58
- Issue
- 7
- Pages
- 970-976
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164800826
- Cited by
- 95
- References
- 24
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 6 · 2017: 8 · 2016: 13 · 2015: 13 · 2014: 10
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-89918)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Xpert MTB/RIF, tuberculosis diagnosis, Mycobacterium tuberculosis detection, diagnostic sensitivity, induced sputum, smear-negative tuberculosis, smear-positive tuberculosis, time to diagnosis, high-resource settings, low-incidence tuberculosis, automated molecular diagnostics, tuberculosis treatment initiation
- MeSH terms
- Adult, Canada, DNA, Bacterial, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Sensitivity and Specificity, Tuberculosis, Incidence, Developed Countries, Point-of-Care Systems, Nucleic Acid Amplification Techniques, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.